Brief: Cytek Biosciences sees FY revenue USD 205-220 million
09/05/2023 22:55
May 9 (Reuters) - Cytek Biosciences Q1 revenue USD 37.088 million. * Q1 pretax profit USD -9.04 million * Q1 net income USD -6.807 million * Q1 adjusted EBITDA USD -2.524 million * Outlook FY revenue USD 205-220 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million